Overall survival in patients with FIGO stage IVA cervical cancer-Reference-Cited by-同舟云学术

Overall survival in patients with FIGO stage IVA cervical cancer

Published:2022-08 Issue:2 Volume:166 Page:292-299
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Schiff Joshua P.,Mintz Rachel,Cohen Alexander C.,Huang Yi,Thaker Premal,Massad Leslie S.,Powell Matthew,Mutch David,Schwarz Julie K.,Markovina Stephanie T.,Grigsby Perry W.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference38 articles.

1. Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer;Brodeur;Gynecol. Oncol.,2021

2. Outcome of stage IVA cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: a Gynecologic Oncology Group study;Rose;Gynecol. Oncol.,2011

3. Radiation therapy for stage IVA cervical cancer;Murakami;Anticancer Res.,2013

4. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study;Pötter;Lancet Oncol.,2021

5. Pelvic irradiation with concurrent chemotherapy versus pelvic and Para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01;Eifel;J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol.,2004

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of stage IVA cervical cancer treatment: Challenges in the management of an understudied group;Gynecologic Oncology;2024-08

2. Successful management of locally advanced cervical cancer via total pelvic exenteration following neoadjuvant chemotherapy;Journal of Surgical Case Reports;2024-07-01

3. Management and long-term clinical outcomes of patients with stage IVA cervical cancer with bladder involvement;Gynecologic Oncology;2024-01

4. Characteristics, treatment patterns, and outcomes in patients with high-risk locally advanced cervical cancer;Cancer Treatment and Research Communications;2024

5. A novel cervix carcinoma biomarker: Pathological-epigenomics, integrated analysis of MethylMix algorithm and pathology for predicting response to cancer immunotherapy;Frontiers in Oncology;2022-11-02